Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma
NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein...
Saved in:
| Main Authors: | Mara Giavina-Bianchi, Pedro Giavina-Bianchi, Mirian Nacagami Sotto, Alona Muzikansky, Jorge Kalil, Cyro Festa-Neto, Lyn M. Duncan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/761378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of action of over-expressing NY-ESO-1 in vesicular stomatitis virus and its combination therapy with NY-ESO-1 TCR-T
by: Ting Tian, et al.
Published: (2025-08-01) -
Histopathological analysis of the skin of renal transplant recipients submitted to three different immunosuppression regimens
by: Maria Victória Quaresma, et al.
Published: (2025-08-01) -
Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report
by: Deepak Kumar, et al.
Published: (2020-10-01) -
Da(ny) goes (auto)graphic
by: Anne Brüske
Published: (2023-06-01) -
Comparing oxidative metabolism in patients with uveal melanoma versus cutaneous melanoma
by: Mihai Adrian Păsărică, et al.
Published: (2022-01-01)